However, Wooten et al. did not find any alterations in blood markers associated with protein synthesis and degradation, such as myostatin, follistatin, and growth hormone [41], and in the systematic review by Cheema et al., no significant differences were found regarding body mass composition in breast cancer survivor patients [79]. This evidence concerns the gene GH1 and breast carcinoma.